Skip to main content
Signal8
Launch Terminal
IWAKI YUICHI profile photo

Yuichi Iwaki

CIK: 0001263965

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MEDICINOVA INC logo
MNOV

MEDICINOVA INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Jan 16, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    450K shares-
  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Feb 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    100K shares-
  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Jan 7, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    400K shares-

1-3 of 3

About IWAKI YUICHI

IWAKI YUICHI (SEC CIK 0001263965) files insider reports with the SEC as President and CEO of MEDICINOVA INC (MNOV).

Signal8 holds 3 ownership filings by IWAKI YUICHI, all Form 4s, filed between Jan 10, 2025 and Jan 20, 2026. Those filings report 3 transactions, from Jan 7, 2025 to Jan 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on IWAKI YUICHI's filings is in LA JOLLA, CA.

Recent filings by IWAKI YUICHI

  • Jan 16, 2026: Grant or award of MNOV derivative securities (Form 4, code A).
  • Feb 12, 2025: Grant or award of MNOV derivative securities (Form 4, code A).
  • Jan 7, 2025: Grant or award of MNOV derivative securities (Form 4, code A).

Other insiders filing for MEDICINOVA INC (MNOV)

How to read Form 4 transaction codes